MICB and plasma cell myeloma: In multiple myeloma cells, LXRs activation enhanced the NK cell-cytotoxicity activity by upregulating the NKG2D ligands, namely, MHC class I polypeptide-related sequence-A (MICA) and MICB respectively (Bilotta et al., 2019).